206 related articles for article (PubMed ID: 10647878)
21. Second malignancies following treatment for Hodgkin's disease: a Greek experience.
Economopoulos T; Stathakis N; Alexopoulos C; Pavlidis N; Constantinidou M; Briassoulis E; Papageorgiou E; Dervenoulas J; Pappa V; Vaslamatzis M
Haematologica; 1994; 79(3):273-6. PubMed ID: 7926979
[TBL] [Abstract][Full Text] [Related]
22. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
Glanzmann C; Veraguth A; Lütolf UM
Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
[TBL] [Abstract][Full Text] [Related]
23. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.
van Leeuwen FE; Somers R; Taal BG; van Heerde P; Coster B; Dozeman T; Huisman SJ; Hart AA
J Clin Oncol; 1989 Aug; 7(8):1046-58. PubMed ID: 2754447
[TBL] [Abstract][Full Text] [Related]
24. Incidence of non-Hodgkin's lymphoma in patients treated for Hodgkin's disease.
Prósper F; Robledo C; Cuesta B; Rifón J; Borbolla JR; Pardo J; Rocha E
Leuk Lymphoma; 1994 Feb; 12(5-6):457-62. PubMed ID: 8180608
[TBL] [Abstract][Full Text] [Related]
25. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.
Swerdlow AJ; Barber JA; Horwich A; Cunningham D; Milan S; Omar RZ
Br J Cancer; 1997; 75(1):116-23. PubMed ID: 9000608
[TBL] [Abstract][Full Text] [Related]
26. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voûte PA; Morris-Jones P; Greenberg M
Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
[TBL] [Abstract][Full Text] [Related]
27. Second cancers among long-term survivors of non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Glimelius B; Holowaty E; Van Leeuwen FE; Lynch CF; Adami J; Gospodarowicz M; Wacholder S; Inskip P
J Natl Cancer Inst; 1993 Dec; 85(23):1932-7. PubMed ID: 8230284
[TBL] [Abstract][Full Text] [Related]
28. The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital.
Cellai E; Magrini SM; Masala G; Alterini R; Costantini AS; Rigacci L; Olmastroni L; Papi MG; Spediacci MA; Innocenti F; Bellesi G; Ferrini PR; Biti G
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1327-37. PubMed ID: 11286841
[TBL] [Abstract][Full Text] [Related]
29. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.
Dores GM; Metayer C; Curtis RE; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; van Leeuwen FE; Holowaty EJ; Andersson M; Wiklund T; Joensuu T; van't Veer MB; Stovall M; Gospodarowicz M; Travis LB
J Clin Oncol; 2002 Aug; 20(16):3484-94. PubMed ID: 12177110
[TBL] [Abstract][Full Text] [Related]
30. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk.
Franklin JG; Paus MD; Pluetschow A; Specht L
Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD003187. PubMed ID: 16235316
[TBL] [Abstract][Full Text] [Related]
32. Second solid malignancies after combined modality therapy for Hodgkin's disease.
Doria R; Holford T; Farber LR; Prosnitz LR; Cooper DL
J Clin Oncol; 1995 Aug; 13(8):2016-22. PubMed ID: 7636543
[TBL] [Abstract][Full Text] [Related]
33. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
[TBL] [Abstract][Full Text] [Related]
34. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.
van Leeuwen FE; Klokman WJ; Veer MB; Hagenbeek A; Krol AD; Vetter UA; Schaapveld M; van Heerde P; Burgers JM; Somers R; Aleman BM
J Clin Oncol; 2000 Feb; 18(3):487-97. PubMed ID: 10653864
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer and other second neoplasms after childhood Hodgkin's disease.
Bhatia S; Robison LL; Oberlin O; Greenberg M; Bunin G; Fossati-Bellani F; Meadows AT
N Engl J Med; 1996 Mar; 334(12):745-51. PubMed ID: 8592547
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the risk of solid tumor following Hodgkin's disease.
Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084
[TBL] [Abstract][Full Text] [Related]
37. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
Salloum E; Doria R; Schubert W; Zelterman D; Holford T; Roberts KB; Farber LR; Kiehl RK; Cardinale J; Cooper DL
J Clin Oncol; 1996 Sep; 14(9):2435-43. PubMed ID: 8823321
[TBL] [Abstract][Full Text] [Related]
38. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
[TBL] [Abstract][Full Text] [Related]
39. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
40. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.
Bhatia S; Yasui Y; Robison LL; Birch JM; Bogue MK; Diller L; DeLaat C; Fossati-Bellani F; Morgan E; Oberlin O; Reaman G; Ruymann FB; Tersak J; Meadows AT;
J Clin Oncol; 2003 Dec; 21(23):4386-94. PubMed ID: 14645429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]